The company anticipates submitting a biologics licence application for accelerated approval in the US in early 2026.

The FDA has granted Orphan Drug Designation to NeuroNOS's BA-102 ... which may lead to skepticism about the viability of the treatment. The timeline for initiating first-in-human U.S. clinical ...